Cargando…

Candidate targets for antibody therapy of rheumatoid arthritis: CD64 and IL-15

Detalles Bibliográficos
Autor principal:	van de Winkel, J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833833/ http://dx.doi.org/10.1186/ar843

Ejemplares similares

Anti-TNF antibody therapy induces IL-17 suppressing regulatory T cells in patients with rheumatoid arthritis
por: McGovern, Jenny, et al.
Publicado: (2012)

IL-17, synoviolin and rheumatoid arthritis chronicity
por: Miossec, Pierre
Publicado: (2012)

OA21 Are novel anti-IL5 biologics triggering rheumatoid arthritis?
por: Dean, Nathan, et al.
Publicado: (2023)

IL-15 and its role in rheumatoid arthritis
por: Kurowska-Stolarska, M, et al.
Publicado: (2003)

Therapeutic targets for rheumatoid arthritis: lessons from animal models
por: Iwakura, Yoichiro, et al.
Publicado: (2012)

Markers in rheumatoid arthritis
por: Breedveld, FC
Publicado: (2004)

IFN-β for the treatment of rheumatoid arthritis?
por: Tak, P, et al.
Publicado: (2003)

Regulation of inflammatory immune responses leading to the development of bone destructive autoimmune disease rheumatoid arthritis by IL-27
por: Yoshimoto, Takayuki, et al.
Publicado: (2012)

Overview of biotherapy in rheumatoid arthritis (RA)
por: Takeuchi, Tsutomu, et al.
Publicado: (2012)

OA17 Rheumatoid meningitis - a rare complication of rheumatoid arthritis
por: Ibrahim, Asma, et al.
Publicado: (2023)

Premise: traditional disease-modifying antirheumatic drugs are less effective and safe than targeted therapy with biologic response modifiers in rheumatoid arthritis
por: Fleischmann, R
Publicado: (2003)

Evidence for synovial fibroblasts spreading rheumatoid arthritis
por: Müller-Ladner, Ulf, et al.
Publicado: (2012)

Signal transduction inhibitors for the treatment of rheumatoid arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2012)

Angiogenesis in rheumatoid arthritis: the role of fut 1
por: Koch, Alisa Erika
Publicado: (2012)

Adverse effects of rheumatoid arthritis on bone remodeling
por: Goldring, SR, et al.
Publicado: (2004)

The role of Bob1 in rheumatoid arthritis: potential implications for autoimmunity
por: Yeremenko, Nataliya, et al.
Publicado: (2012)

Chemokines in rheumatoid arthritis: novel, potential therapeutic targets of the CCR2 chemokine receptor signaling pathway
por: Matsushima, K, et al.
Publicado: (2003)

Fifty years' experience in resarch for pathogenesis of rheumatoid arthritis.
por: Zvaifler, NJ
Publicado: (2003)

Skeletal involvement in the pathogenesis and outcomes of rheumatoid arthritis and osteoarthritis
por: Pelletier, Jean-Pierre
Publicado: (2012)

Hyper-ERAD: a novel pathomechanism for rheumatoid arthritis
por: Nakajima, T, et al.
Publicado: (2004)

Rheumatoid arthritis: a heterogeneous disease evaluated by DNA-microarray technology
por: Kasperkovitz, PV, et al.
Publicado: (2004)

14.6 MRP-Targeting in experimental rheumatoid arthritis allows monitoring of disease activity with optical molecular imaging
por: Eisenblätter, M, et al.
Publicado: (2008)

SKG mice, a new genetic model of rheumatoid arthritis
por: Sakaguchi, S, et al.
Publicado: (2003)

Cell biology of synovial inflammation and secondary osteoporosis in rheumatoid arthritis
por: Tanaka, Y, et al.
Publicado: (2003)

Molecular signatures of rheumatoid arthritis characterized by transcriptome and proteome analysis
por: Glocker, MO, et al.
Publicado: (2005)

Genome-wide single nucleotide polymorphism analyses on rheumatoid arthritis
por: Yamamoto, K, et al.
Publicado: (2004)

Development of the Salford Rheumatoid Arthritis Foot Evaluation Instrument (SAFE)
por: Walmsley, Steven, et al.
Publicado: (2013)

The role of IL-17 in the development of arthritis in mouse models
por: Iwakura, Y, et al.
Publicado: (2003)

IL-15 deficient Tax mice reveal a role for IL-1α in tumor immunity
por: Rauch, Daniel A, et al.
Publicado: (2014)

Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis
por: Wunder, A, et al.
Publicado: (2003)

Podiatrists’ perspectives of the provision of foot health education for people with Rheumatoid Arthritis
por: Graham, Andrea, et al.
Publicado: (2010)

Prevalence of MTP joint involvement in the painful forefoot of patients with Rheumatoid Arthritis
por: Siddle, Heidi, et al.
Publicado: (2010)

S6.4c Primary cutaneous implantation coccidioidomycosis
por: Bonifaz, Alexandro, et al.
Publicado: (2022)

Mechanisms of resistance against Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts
por: Pap, T, et al.
Publicado: (2003)

Occurrence and risk factors for falls in adults with rheumatoid arthritis: a systematic review
por: Brenton-Rule, Angela, et al.
Publicado: (2013)

Clinical practice guidelines for the foot and ankle in rheumatoid arthritis: a critical appraisal
por: Hennessy, Kym, et al.
Publicado: (2013)

Podiatry care in rheumatoid arthritis: differences between current and ideal service provision
por: Hennessy, Kym, et al.
Publicado: (2013)

Foot involvement in early rheumatoid arthritis: a prospective study of ultrasound features
por: Newcombe, Lisa, et al.
Publicado: (2013)

Pathogenic roles of IL-6 and IL-6 blocking therapy on rheumatoid arthritis
por: Yoshizaki, K, et al.
Publicado: (2003)

6.4 Spondylo-epiphyseal dysplasia – a physiotherapy approach
por: Mato, H, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_h5dk5160djfokfsmbn3468g0dg